291 related articles for article (PubMed ID: 17216591)
1. Effect of hyperimmune plasma on the severity of pneumonia caused by Rhodococcus equi in experimentally infected foals.
Caston SS; McClure SR; Martens RJ; Chaffin MK; Miles KG; Griffith RW; Cohen ND
Vet Ther; 2006; 7(4):361-75. PubMed ID: 17216591
[TBL] [Abstract][Full Text] [Related]
2. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals.
Giguère S; Gaskin JM; Miller C; Bowman JL
J Am Vet Med Assoc; 2002 Jan; 220(1):59-63. PubMed ID: 12680449
[TBL] [Abstract][Full Text] [Related]
4. Antibody activities in hyperimmune plasma against the Rhodococcus equi virulence -associated protein A or poly-N-acetyl glucosamine are associated with protection of foals against rhodococcal pneumonia.
Kahn SK; Cywes-Bentley C; Blodgett GP; Canaday NM; Turner-Garcia CE; Vinacur M; Cortez-Ramirez SC; Sutter PJ; Meyer SC; Bordin AI; Vlock DR; Pier GB; Cohen ND
PLoS One; 2021; 16(8):e0250133. PubMed ID: 34437551
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of equine immunoglobulin specific for Rhodococcus equi virulence-associated proteins A and C for use in protecting foals against Rhodococcus equi-induced pneumonia.
Hooper-McGrevy KE; Giguere S; Wilkie BN; Prescott JF
Am J Vet Res; 2001 Aug; 62(8):1307-13. PubMed ID: 11497456
[TBL] [Abstract][Full Text] [Related]
6. Effect of prophylactic administration of hyperimmune plasma to prevent Rhodococcus equi infection on foals from endemically affected farms.
Higuchi T; Arakawa T; Hashikura S; Inui T; Senba H; Takai S
Zentralbl Veterinarmed B; 1999 Nov; 46(9):641-8. PubMed ID: 10605374
[TBL] [Abstract][Full Text] [Related]
7. Use of Rhodococcus equi virulence-associated protein for immunization of foals against R equi pneumonia.
Prescott JF; Nicholson VM; Patterson MC; Zandona Meleiro MC; Caterino de Araujo A; Yager JA; Holmes MA
Am J Vet Res; 1997 Apr; 58(4):356-9. PubMed ID: 9099378
[TBL] [Abstract][Full Text] [Related]
8. Failure of hyperimmune plasma to prevent pneumonia caused by Rhodococcus equi in foals.
Hurley JR; Begg AP
Aust Vet J; 1995 Nov; 72(11):418-20. PubMed ID: 8929188
[TBL] [Abstract][Full Text] [Related]
9.
Sanz MG; Bradway DS; Horohov DW; Baszler TV
Vet Rec; 2019 Jul; 185(1):19. PubMed ID: 30995996
[No Abstract] [Full Text] [Related]
10. Rhodococcus equi foal pneumonia: protective effects of immune plasma in experimentally infected foals.
Martens RJ; Martens JG; Fiske RA; Hietala SK
Equine Vet J; 1989 Jul; 21(4):249-55. PubMed ID: 2767025
[TBL] [Abstract][Full Text] [Related]
11. Immunization by intrabronchial administration to 1-week-old foals of an unmarked double gene disruption strain of Rhodococcus equi strain 103+.
Pei Y; Nicholson V; Woods K; Prescott JF
Vet Microbiol; 2007 Nov; 125(1-2):100-10. PubMed ID: 17560744
[TBL] [Abstract][Full Text] [Related]
12. Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection.
Chaffin MK; Cohen ND; Martens RJ; Edwards RF; Nevill M; Smith R
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):33-48. PubMed ID: 15182994
[TBL] [Abstract][Full Text] [Related]
13. Rhodococcus equi hyperimmune plasma decreases pneumonia severity after a randomised experimental challenge of neonatal foals.
Sanz MG; Loynachan A; Horohov DW
Vet Rec; 2016 Mar; 178(11):261. PubMed ID: 26932206
[TBL] [Abstract][Full Text] [Related]
14. Immunoprophylaxis of Rhodococcus equi pneumonia in foals.
Becú T; Polledo G; Gaskin JM
Vet Microbiol; 1997 Jun; 56(3-4):193-204. PubMed ID: 9226834
[TBL] [Abstract][Full Text] [Related]
15. Administration of commercial Rhodococcus equi specific hyperimmune plasma results in variable amounts of IgG against pathogenic bacteria in foals.
Sanz MG; Oliveira AF; Page A; Horohov DW
Vet Rec; 2014 Nov; 175(19):485. PubMed ID: 25117301
[TBL] [Abstract][Full Text] [Related]
16. VapA-specific IgG and IgG subclasses responses after natural infection and experimental challenge of foals with Rhodococcus equi.
Sanz MG; Villarino N; Ferreira-Oliveira A; Horohov DW
Vet Immunol Immunopathol; 2015 Mar; 164(1-2):10-5. PubMed ID: 25681111
[TBL] [Abstract][Full Text] [Related]
17. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.
Cauchard J; Sevin C; Ballet JJ; Taouji S
Vet Microbiol; 2004 Nov; 104(1-2):73-81. PubMed ID: 15530741
[TBL] [Abstract][Full Text] [Related]
18. Current understanding of the equine immune response to Rhodococcus equi. An immunological review of R. equi pneumonia.
Dawson TRMY; Horohov DW; Meijer WG; Muscatello G
Vet Immunol Immunopathol; 2010 May; 135(1-2):1-11. PubMed ID: 20064668
[TBL] [Abstract][Full Text] [Related]
19. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi.
Lopez AM; Hines MT; Palmer GH; Knowles DP; Alperin DC; Hines SA
Vaccine; 2003 Sep; 21(25-26):3815-25. PubMed ID: 12922115
[TBL] [Abstract][Full Text] [Related]
20. Validation and evaluation of VapA-specific IgG and IgG subclass enzyme-linked immunosorbent assays (ELISAs) to identify foals with Rhodococcus equi pneumonia.
Sanz MG; Oliveira AF; Loynachan A; Page A; Svansson V; Giguère S; Horohov DW
Equine Vet J; 2016 Jan; 48(1):103-8. PubMed ID: 25257622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
